Global Clinical Trial Imaging Market Size By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound), By End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers), By Geographic Scope And Forecast

Clinical Trial Imaging Market Size And Forecast

Clinical Trial Imaging Market size was valued at USD 963 Million in 2020 and is projected to reach USD 1,518 Million by 2028, growing at a CAGR of 5.9% from 2021 to 2028.

The Global Clinical Trial Imaging Market is expected to witness significant growth during the forecast period due to increased spending for research and development, and an increasing number of pharmaceutical and biotechnological industries. The Global Clinical Trial Imaging Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Clinical Trial Imaging Market Definition

A clinical trial is an important part of the drug development process. However, the cost of conducting clinical trials has increased in past few years. Therefore, clinical trial imaging is emerging as an alternative measure that will help reduce the cost of the drug trial as well as will improve the timeline of clinical trials.

Global Clinical Trial Imaging Market Overview

Medical imaging plays an important role in the clinical development of novel life science products. Although the medical imaging industry is in a constant state of fluctuation, the biotechnology, as well as pharmaceutical industries, continue to increase. This is attributed to enhanced investment in medical imaging companies as well as mergers and acquisitions along with the adoption of innovative imaging technologies to support clinical trials for medical devices. However, the high cost of machinery, their installation, and the high capital required to run clinical trials will restrain the growth of the market.

Advancements in technology are enabling substantial improvements in the collection, evaluation, as well as submission of clinical trial imaging data. Technology-enabled imaging, especially image analysis software, offers numerous benefits such as data accuracy, consistency, adaptability, and compliance, to clinical studies. For instance, image analysis software is implemented to manage and direct a reader via analysis of imaging time points.

The increasing use of technology along with the enhanced power of computing is boosting the use of imaging in clinical trials. The Quantitative Imaging Biomarkers Alliance (QIBA) protocol offers standardized methods as well as imaging procedures with uniform procedures that can be implemented to attain precise as well as statistical endpoints in clinical trials.

Global Clinical Trial Imaging Market Segmentation Analysis

The Global Clinical Trial Imaging Market is segmented on the basis of Modality, End User, And Geography.

Clinical Trial Imaging Market, By Modality

• Computed Tomography
• Magnetic Resonance Imaging
• Ultrasound
• Positron Emission Tomography
• X-Ray
• Echocardiography
• Other Modalities

Based on Modality, the market is segmented into Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, and Other Modalities. Computed tomography is a non-invasive medical procedure that uses X-Ray to generate cross-sectional images of the body. CT scan provides detailed information to plan treatment as well as examine abnormalities in children and adults. Radiological imaging combined with specific molecular assays acts as a valuable tool to help in the go and no-go decision in preclinical as well as clinical settings.

Clinical Trial Imaging Market, By End User

• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Manufacturers
• Contract Research Organizations
• Academic and Government Research Institutes
• Other End-Users

Based on End-User, the market is bifurcated into Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic and Government Research Institutes, and Other End-Users. Snowballing the cost of drug development along with increased research and development activities is contributing to the growth of the segment. Contract research outsourcing collaborations also offer several cutting-edge services. Therefore, government organizations always prefer the handover of projects to CROs.

Clinical Trial Imaging Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on regional analysis, the Global Clinical Trial Imaging Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The Asia Pacific is anticipated to experience the highest growth during the forecast period. The increasing incidence of chronic diseases, as well as the growing need for better diagnostic devices, are stimulating the growth of the regional market. Apart from this, the surging demand for specialized and quality healthcare facilities to improve patient’s life will also boost the overall market growth.

Key Players

The “Global Clinical Trial Imaging Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Parexel International Corporation, Biomedical Systems Corporation, Biotelemetry, Inc., Cardiovascular Imaging Technologies LLC, Intrinsic Imaging LLC, Radiant Sage LLC, and Worldcare Clinical, LLC. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• On January 2021, Bioclinica, an integrated solutions provider of clinical life science and technology expertise, announced the release of Image Redact AI, a new product that will support the redaction of sensitive patient information from videos, photos, as well as PDFs in clinical trials.
• On December 2020, The merger of ERT and Bioclinica will create a global leader in clinical trial endpoint technology. The transaction will combine Bioclinica’s imaging expertise with ERT’s expertise in eCOA, cardiac safety, respiratory, as well as wearables.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.